Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

about

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

Item

http://www.wikidata.org/entity/Q57492406

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

@en

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

@nl

type

Item

label

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

@en

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

@nl

prefLabel

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

@en

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

@nl

P1476

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

@en

P2093

Ana P F Trombone

http://www.w3.org/2001/XMLSchema#string

Andrea F F Belone

http://www.w3.org/2001/XMLSchema#string

Cleverson T Soares

http://www.w3.org/2001/XMLSchema#string

Cássio C Ghidella

http://www.w3.org/2001/XMLSchema#string

Luciana R V Fachin

http://www.w3.org/2001/XMLSchema#string

Patricia S Rosa

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of a novel human aldose reductase-like gene

Corticosteroids for treating nerve damage in leprosy

Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design

Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways

Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib.

Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis

Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.

Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions

AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling

Thalidomide-a notorious sedative to a wonder anticancer drug.

P304

263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2018.00263

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30320113

http://www.w3.org/2001/XMLSchema#string

P921

Abïl

biomarker

P932

6166685

http://www.w3.org/2001/XMLSchema#string